Abstract
Substance use disorder (SUD) in adolescence is a serious mental health and social problem with its significant association with morbidity and mortality. Substance abuse has progressed from the more antisocial, risk-taking, and marginal groups of the population to the mainstream of society and dramatically to younger populations, reinforcing and expanding the boundaries of at-risk populations for SUD. Research in the area of adolescent substance use has expanded significantly over time, and while many studies have contributed to the growth of knowledge in this area, ongoing study remains important. Substance use may be seen through a developmental perspective progressing across adolescence into young adulthood. We have included the most recent studies and research findings on adolescent substance use and related disorders in this chapter. The chapter will focus on enhancing knowledge and comprehension of adolescent substance abuse in addressing the following areas: epidemiology, vulnerability and developmental course, comorbidity, assessment, treatment, and outcomes. The transitional period of adolescence presents itself as an especially critical and vulnerable time for the onset of substance use disorder (SUD) with its impact on normal development, future SUD, and for society as a whole. Adolescence is a period of major risk for the onset of SUD. Treatment approaches must be tailored to developmental patterns of substance use and include comprehensive assessment and a holistic approach. High rates of comorbid mental disorders among adolescents with SUD further emphasize the need for psychiatric care. An integrated approach to treatment for youth with SUD and comorbid mental disorders is paramount to effective intervention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aarons GA, Brown SA, Hough RL et al (2010) Prevalence of substance use disorders across five sectors of care. J Am Acad Child Adolesc Psychiatry 40(4):419–426
Abrantes AM, Brown SA, Tomlinson KL (2003) Psychiatric comorbidity among inpatient substance abusing adolescents. J Child Adolesc Subst 13(2):83–101
Ahuja AS, Crome I, Williams R (2013) Engaging young people who misuse substances in treatment. Curr Opin Psychiatry 28:335–342
American Academy of Child and Adolescent Psychiatry (AACAP) (2005) Practice parameter for the assessment and treatment of children and adolescents with substance use disorders. J Am Acad Child Adolesc Psychiatry 44:609–621
American Society of Addiction Medicine (ASAM) (2001) ASAM PPC-2R: ASAM Patient Placement Criteria for the Treatment of Substance-Related Disorders. 2nd ed. revised. American Society of Addiction Medicine, Chevy Chase
Anderson KG, Ramo DE, Schulte MT et al (2007) Substance use treatment outcomes for youth: integrating personal and environmental predictors. Drug Alcohol Depend 88:42–48
Anthony JC, Petronis KR (1995) Early-onset drug use and risk of later drug problems. Drug Alcohol Depend 40:9–15
Armstrong TD, Costello EJ (2002) Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity. J Consult Clin Psychol 70(6):1224–1239
August GJ, Winters KC, Realmuto GM et al (2006) Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. J Am Acad Child Adolesc Psychiatry 45(7):824–832
Barkley RA, Fischer M, Smallish L et al (2003) Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 111(1):97–109
Barkley RA, Fischer M, Smallish L et al (2004) Young adult follow-up of hyperactive children: antisocial activities and drug use. J Child Psychol Psychiatry 45(2):195–211
Biederman J, Wilens T, Mick E et al (1997) Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 36(1):21–29
Biederman J, Monuteaux MC, Spencer T et al (2008) Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry 165(5):597–603
Brannigan R, Schackman BR, Falco M et al (2004) The quality of highly regarded adolescent substance abuse treatment programs. Results of an in-depth survey. Arch Pediatr Adolesc Med 158:904–909
Brent DA, Perper JA, Moritz G et al (1993) Psychiatric risk factors for adolescent suicide: a case-control study. J Am Acad Child Adolesc Psychiatry 32(3):521–529
Brook JS, Cohen P, Brook DW (1998) Longitudinal study of co-occurring psychiatric disorders and substance use. J Am Acad Child Adolesc Psychiatry 37(3):322–330
Brook DW, Brook JS, Zhang C et al (2002) Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry 59:1039–1044
Brook DW, Brook JS, Zhang C et al (2010) Association between attention-deficit/hyperactivity disorder in adolescence and substance use disorders in adulthood. Arch Pediatr Adolesc Med 164(10):930–934
Brown SA, D’Amico EJ, McCarthy DM et al (2001) Four-year outcomes from adolescent alcohol and drug treatment. J Stud Alcohol 62:381–388
Brown SA, McGue M, Maggs J et al (2008) A developmental perspective on alcohol and youths 16 to 20 years of age. Pediatrics 21(4):S290–S310
Bukstein OG, Glancy LJ, Kaminer Y (1992) Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J Am Acad Child Adolesc Psychiatry 31(6):1041–1045
Burleson JA, Kaminer Y (2006) Adolescent alcohol and marijuana use: concordance among objective-, self-, and collateral-reports. J Child Adolesc Subst 16(1):53–68
Casey BJ, Jones RM (2010) Neurobiology of the adolescent brain and behavior: implications for substance use disorders. Am Acad Child Adolesc Psychiatry 49(12):1189–1201
Charach A, Yeung E, Climans T (2011) Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry 50(1):9–21
Chen P, Jacobson KC (2012) Developmental trajectories of substance use from early adolescence to young adulthood: gender and racial/ethnic differences. J Adolesc Health 50(2):154–163
Chen K, Kandel DB, Davies M (1997) Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States. Drug Alcohol Depend 46:53–67
Chen CY, O’Brien MS, Anthony JC (2005) Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001. Drug Alcohol Depend 79:11–22
Chung T, Maisto SA (2006) Relapse to alcohol and other drug use in adolescents: review and reconsideration of relapse as a change point in clinical course. Clin Psychol Rev 26:149–161
Clark DB, Pollock N, Bukstein O et al (1997) Gender and comorbid psychopathology in adolescents with alcohol dependence. J Am Acad Child Adolesc Psychiatry 36(9):1195–1203
Coffey C, Carlin JB, Lynskey M et al (2003) Adolescent precursors of cannabis dependence: findings from the Victorian Adolescent Health Cohort Study. Br J Psychiatry 182:330–336
Committee on Substance Abuse (2011) Substance use screening, brief intervention, and referral to treatment for pediatricians. Pediatrics 128:e1330
Compton WM, Thomas YF, Stinson FS et al (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States. Arch Gen Psychiatry 64:566–567
Conway KP, Vullo GC, Nichter B et al (2013) Prevalence and patterns of polysubstance use in a nationally representative sample of 10th graders in the United States. J Adolesc Health 52:716–723
Copeland WE, Shanahan L, Costello EJ et al (2009) Childhood and adolescent psychiatric disorders as predictors of young adult disorders. Arch Gen Psychiatry 66(7):764–772
Cornelius JR, Clark DB, Bukstein OG et al (2005) Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review. Addict Behav 30:1824–1833
Cornelius JR, Chung T, Martin D et al (2008) Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence. Addict Behav 33:1500–1505
Cornelius JR, Bukstein OG, Wood S et al (2009) Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder. Addict Behav 34:905–909
Costello EJ, Mustillo S, Erkanli A et al (2003) Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 60:837–844
Crumley FE (1990) Substance abuse and adolescent suicidal behavior. J Am Med Assoc 263(22):3051–3056
Curry J, Silva S, Rohde P et al (2012) Onset of alcohol or substance use disorders following treatment for adolescent depression. J Consult Clin Psychol 80(2):299–312
Dawes MA, Johnson BA, Ait-Daoud N et al (2005) A prospective, open-label trial of ondansetron in adolescents with alcohol dependence. Addict Behav 30:1077–1085
de Dios MA, Vaughan EL, Stanton CA et al (2009) Adolescent tobacco use and substance abuse treatment outcomes. J Subst Abuse Treat 37:17–24
Deas D (2006) Adolescent substance abuse and psychiatric comorbidities. J Clin Psychiatry 67(7):18–23
Deas D, Randall CL, Roberts JS et al (2000) A double-blind, placebo- controlled trial of sertraline in depressed adolescent alcoholics: a pilot study. Hum Psychopharmacol Clin Exp 15:461–469
Deas D, May K, Randall C et al (2005) Naltrexone treatment of adolescent alcoholics: an open-label pilot study. J Child Adolesc Psychopharmacol 15(5):723–728
Degenhardt L, Dierker L, Chiu WT et al (2010) Evaluating the ‘gateway’ theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug Alcohol Depend 108:84–97
Dennis M, Babor TF, Roebuck C et al (2002) Changing the focus: the case for recognizing and treating cannabis use disorders. Addiction 97(1):4–15
Dennis M, Godley SH, Diamond G et al (2004) The Cannabis Youth Treatment (CYT) study: main findings from two randomized trials. J Subst Abuse Treat 27:197–213
DeWit DJ, Adlaf EM, Offord DR et al (2000) Age at first alcohol use: a risk factor for the development of alcohol disorders. Am J Psychiatry 157:745–750
Deykin EY, Buka SL, Zeena TH (1992) Depressive illness among chemically dependent adolescents. Am J Psychiatry 149(10):1341–1347
Diamond GS, Liddle HA, Wintersteen MB et al (2006) Early therapeutic alliance as a predictor of treatment outcome for adolescent cannabis users in outpatient treatment. Am J Addict 15:26–33
Disney ER, Elkins IJ, McGue M et al (1999) Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. Am J Psychiatry 156(10):1515–1521
Duffy A, Milin R (1996) Case study: withdrawal syndrome in adolescent chronic cannabis users. J Am Acad Child Adolesc Psychiatry 35(12):1618–1621
Elkins IJ, McGue M, Iacono WG (2007) Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry 64(10):1145–1152
Esposito-Smythers C, Spirito A (2004) Adolescent substance use and suicidal behavior: a review with implications for treatment research. Alcohol Clin Exp Res 28(5):77s–88s
Fergusson DM, Lynskey MT (1996) Adolescent resiliency to family adversity. J Child Psychol Psychiatry 37(3):281–292
Fergusson DM, Boden JM, Horwood LJ (2006a) Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 101:556–569
Fergusson DM, Boden JM, Horwood LJ (2006b) Testing the cannabis gateway hypothesis: replies to Hall, Kandel et al. and Maccoun (2006). Addiction 101:474–476
Fishman M (2008) Treatment planning, matching, and placement for adolescents with substance use disorders. In: Kaminer Y, Bukstein OG (eds) Adolescent substance abuse, psychiatric comorbidity and high-risk behaviors. Taylor & Francis, New York, pp 87–110
Fishman MJ, Winstanley EL, Curran E et al (2010) Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility. Addiction 105:1669–1676
Geller B, Cooper TB, Sun K et al (1998) Double-blind and placebo-controlled study of lithium for adolescent bipolar disorder with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 37(2):171–178
Giaconia RM, Reinherz HZ, Carmola Hauf A (2000) Comorbidity of substance use and post-traumatic stress disorders in a community sample of adolescents. Am J Orthopsychiatry 70(2):253–262
Gilvarry E (2000) Substance abuse in young people. J Child Psychol Psychiatry 41(1):55–80
Glantz MD, Anthony JC, Berglund PA et al (2009) Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits. Psychol Med 39:1365–1377
Godley MD, Godley SH, Dennis ML et al (2002) Preliminary outcomes from the assertive continuing care experiment for adolescents discharged from residential treatment. J Subst Abuse Treat 23:21–32
Goldstein BI, Shamseddeen W, Spirito A et al (2009) Substance use and the treatment of resistant depression in adolescents. J Am Acad Child Adolesc Psychiatry 48(12):1182–1192
Gray KM, Carpenter MJ, Baker NL et al (2012) A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry 169:805–812
Greenbaum PE, Prange ME, Friedman RM et al (1991) Substance abuse prevalence and comorbidity with other psychiatric disorders among adolescents with severe emotional disturbances. J Am Acad Child Adolesc Psychiatry 30(4):575–583
Grella CE, Hser YI, Joshi V et al (2001) Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis 189(6):384–392
Grilo CM, Becker DF, Walker ML et al (1995) Psychiatric comorbidity in adolescent inpatients with substance use disorders. J Am Acad Child Adolesc Psychiatry 34(8):1085–1091
Grilo CM, Becker DF, Fehon DC et al (1996) Conduct disorder, substance use disorders, and coexisting and substance use disorders in adolescent inpatients. Am J Psychiatry 153(3):914–920
Hawkins JD, Catalano RF, Miller JY (1992) Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull 112(1):64–105
Hayatbakhsh MR, Najman JM, Jamrozik K et al (2007) Cannabis and anxiety and depression in young adults: a large prospective study. J Am Acad Child Adolesc Psychiatry 46(3):408–417
Hopfer C, Salomonsen-Sautel S, Mikulich-Gilbertson S et al (2013) Conduct disorder and initiation of substance use: a prospective longitudinal study. J Am Acad Child Adolesc Psychiatry 52(5):511–518
Horner BR, Scheibe KE (1997) Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. J Am Acad Child Adolesc Psychiatry 36(1):30–36
Horwood LJ, Fergusson DM, Hayatbakhsh MR et al (2010) Cannabis use and educational achievement: findings from three Australian cohort studies. Drug Alcohol Depend 110:247–253
Hser Y, Grella CE, Hubbard RL et al (2001) An evaluation of drug treatments for adolescents in 4 US cities. Arch Gen Psychiatry 58:689–695
Humphreys KL, Eng T, Lee SS (2013) Stimulant medication and substance use outcomes a meta-analysis. JAMA Psychiatry 70(7):740–749
Johnston LD, O’Malley PM, Bachman JG et al (2013) Monitoring the future national results on drug use: 2012 overview, key findings on adolescent drug use. Institute for Social Research, The University of Michigan, Ann Harbor
Kaminer Y, Burleson JA, Burke RH (2008) Efficacy of outpatient aftercare for adolescents with alcohol use disorders: a randomized controlled study. J Am Acad Child Adolesc Psychiatry 47(12):1405–1412
Kamon J, Budney A, Stanger C (2005) A contingency management intervention for adolescent marijuana abuse and conduct problems. J Am Acad Child Adolesc Psychiatry 44(6):513–521
Kandel DB (1975) Stages in adolescent involvement in drug use. Science 190:912–914
Kandel DB (2003) Does marijuana use cause the use of other drugs? J Am Med Assoc 289(4):482–483
Kandel DB, Yamaguchi K, Chen K (1992) Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. J Stud Alcohol 53:447–457
Kandel DB, Johnson JG, Bird HR et al (1999) Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA study. J Am Acad Child Adolesc Psychiatry 38(6):693–699
Katusic SK, Barbaresi WJ, Colligan RC et al (2005) Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Child Adolesc Psychopharmacol 15(5):764–776
King CA, Naylor MW, Hill EM et al (1993) Dysthymia characteristic of heavy alcohol use in depressed adolescents. Biol Psychiatry 33:210–212
King CA, Ghaziuddin N, McGovern L et al (1996) Predictors of comorbid alcohol and substance abuse in depressed adolescents. J Am Acad Child Adolesc Psychiatry 35(6):743–751
Kramer TL, Robbins JM, Phillips SD et al (2003) Detection and outcomes of substance use disorders in adolescents seeking mental health treatment. J Am Acad Child Adolesc Psychiatry 42(11):1318–1326
Large M, Scharma S, Compton MT, Slade T, Neilson O (2011) Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry 68(6):555–561
Macleod J, Oaskes R, Copello A et al (2004) Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 363:1579–1588
Mannuzza S, Klein RG, Truong NL et al (2008) Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry 165(5):604–609
Marsch LA, Bickel WK, Badger GJ et al (2005) Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. Arch Gen Psychiatry 62:1157–1164
Merikangas KR, Jian-ping H, Burstein M et al (2010) Lifetime prevalence of mental disorders in US adolescents: Results from the National Comorbidity Survey Replication-Adolescent supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 49(10):980–989
Milin R, Halikas JA, Meller JE et al (1991) Psychopathology among substance abusing juvenile offenders. J Am Acad Child Adolesc Psychiatry 30(4):569–574
Milin R, Manion I, Dare G, Walker S. (2008) Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study. J Am Acad Child Adolesc Psychiatry 47(2):174–179.
Milin R, Walker S, Duffy A (2010) Assessment and treatment of comorbid psychotic disorders and bipolar disorder. In: Kaminer YK (ed) Clinical manual of adolescent substance abuse treatment. APPI, Arlington, pp 379–414
Molina BS, Pelham WE Jr (2003) Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol 112(3):497–507
Molina BSG, Hinshaw SP, Arnold LE et al (2013) Adolescent substance use in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder (ADHD) (MTA) as a function of childhood ADHD, rand assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry 52(3):250–263
Monti PM, Barnett NP, O’Leary TA et al (2001) Motivational enhancement for alcohol-involved adolescents. In: Monti P, Colby SM, O’Leary TA (eds) Adolescents, alcohol, and substance abuse. Guilford Press, New York, pp 145–182
Moore THM, Zammit S, Lingford-Hughes A et al (2004) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370:319–328
Morral AR, McCaffrey DF, Ridgeay G et al (2006) The relative effectiveness of 10 adolescent substance abuse treatment programs in the United States. RAND Drug Policy Research Center, Santa Monica
Neiderhofer H, Staffen W (2003) Acamprosate and its efficacy in treating alcohol dependent adolescents. Eur Child Adolesc Psychiatry 12:144–148
Newcomb MD (1995) Identifying high-risk youth: prevalence and patterns of adolescent drug abuse. In: Rahdert E, Czechowicz D (eds) Adolescent drug abuse: clinical assessment and therapeutic interventions. National Institute on Drug Abuse, Rockville, pp 7–37
Newcomb MD (1997) Psychosocial predictors and consequences of drug use: a developmental perspective within a prospective study. J Addict Dis 16(1):51–88
Newcomb MD, Felix-Ortiz M (1992) Multiple protective risk factors for drug use and abuse: cross-sectional and prospective findings. J Pers Soc Psychol 63(2):280–296
Palmer RHC, Young SE, Hopfer CJ et al (2009) Developmental epidemiology of drug use and abuse in adolescence and young adulthood: evidence of generalized risk. Drug Alcohol Depend 102:78–87
Pilowsky DJ, Wu L-T (2013) Screening instruments for substance use and brief interventions targeting adolescents in primary care: a literature review. Addict Behav 38:2146–2153
Rao U, Chen LA (2008) Neurobiological and psychosocial processes associated with depressive and substance-related disorders in adolescents. Curr Drug Abuse Rev 1:68–80
Rao U, Ryan ND, Dahl RE et al (1999) Factors associated with the development of substance use disorder in depressed adolescents. J Am Acad Child Adolesc Psychiatry 38(9):1109–1117
Reebye P, Moretti MM, Lessard JC (1995) Conduct disorder and substance use disorder: comorbidity in a clinical sample of preadolescents and adolescents. Can J Psychiatry 40:313–319
Riggs PD, Mikulich SK, Coffman LM et al (1997) Fluoxetine in drug-dependent delinquents with major depression: an open trial. J Child Adolesc Psychopharmacol 7(2):87–95
Riggs PD, Hall SK, Mikulich-Gilbertson SK et al (2004) A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry 43(4):420–429
Riggs PD, Mikulich-Gilbertson SK, Davies RD et al (2007) A randomized controlled trial of fluoxetine and cognitive behavioural therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adoelsc Med 161(11):1026–1034
Riggs PD, Winhusen T, Davies RD et al (2011) Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy with adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry 50(9):903–914
Rigter H, Henderson CE, Pelc I et al (2013) Multidimensional family therapy lowers the rate of cannabis dependence in adolescents: a randomised controlled trial in Western European outpatient settings. Drug Alcohol Depend 130(1–3):85–93
Rohde P, Lewinshohn PM, Seeley JR (1996) Psychiatric comorbidity with problematic alcohol use in high school students. J Am Acad Child Adolesc Psychiatry 35(1):101–109
Rounds-Bryant JL, Kristiansen PL, Fairbank JA et al (1998) Substance use, mental disorders, abuse, and crime: gender comparisons among a national sample of adolescent drug treatment clients. J Child Adolesc Subst Abuse 7(4):19–20
Rowe CL, Liddle HA, Greenbaum PE et al (2004) Impact of psychiatric comorbidity on treatment of adolescent drug abusers. J Subst Abuse Treat 26:129–140
Samet S, Waxman R, Hatzenbuehler M et al (2007) Assessing addiction: concepts and instruments. Addict Sci Clin Pract 40:19–31
Schepis TS, Adinoff B, Rao U (2008) Neurobiological processes in adolescent addictive disorders. Am J Addict 7:6–23
Scholes-Balog KE, Hemphill SA, Patton GC (2013) Cannabis use and related harms in the transition to young adulthood: a longitudinal study of Australian secondary school students. J Adolesc 36:519–527
Shane PA, Jasiukaitis P, Green RS (2003) Treatment outcomes among adolescents with substance abuse problems: the relationship between comorbidities and post-treatment substance involvement. Eval Program Plann 26:393–402
Shedler J, Block J (1990) Adolescent drug use and psychological health: a longitudinal inquiry. Am Psychol 45(5):612–630
Stein LA, Hesselbrock V, Bukstein OG (2008) Conduct disorder and oppositional defiant disorder and adolescent substance use disorders. In: Kaminer Y, Bukstein OG (eds) Adolescent substance abuse psychiatric comorbidity and high-risk behaviors. Routledge Taylor & Francis Group, New York, pp 163–194
Sterling S, Weisner C (2005) Chemical dependency and psychiatric services for adolescents in private managed care: implications for outcomes. Alcohol Clin Exp Res 29(5):801–809
Stowell RJ, Estroff TW (1992) Psychiatric disorders in substance-abusing adolescent inpatients: a pilot study. J Am Acad Child Adolesc Psychiatry 31(6):1036–1040
Subramaniam GA, Stitzer MA, Clemmey P et al (2007) Baseline depressive symptoms predict poor substance use outcome following adolescent residential treatment. J Am Acad Child Adolesc Psychiatry 46(8):1062–1069
Substance Abuse and Mental Health Services Administration (2009) Results from the 2008 national survey on drug use and health: national findings (Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434). Office of Applied Studies, Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services, Rockville
Sung M, Erkanli A, Angold A et al (2004) Effects of age at first substance use and psychiatric comorbidity on the development of substance use disorders. Drug Alcohol Depend 75:287–299
Szobot CM, Rohde LA, Katz B et al (2008) A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder. Braz J Med Biol Res 41(3):250–257
Tanner-Smith EE, Wilson SJ, Lipsey MW (2013) The comparative effectiveness of outpatient treatment for adolescent substance abuse: a meta-analysis. J Subst Abuse Treat 44:145–158
Thurston e C, Riggs PD, Salomonsen-Sautel S et al (2010) Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder. J Am Acad Child Adolesc Psychiatry 49(6):573–582
Tims FM, Dennis ML, Hamilton N et al (2002) Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment. Addiction 97(1):46–57
Tomlinson KL, Brown SA, Abrantes A (2004) Psychiatric comorbidity and substance use treatment outcomes of adolescents. Psychol Addict Behav 18(2):160–169
Upadhyaya HP (2008) Routinely assess substance use disorders (SUDs). J Am Acad Child Adolesc Psychiatry 47(6):610
Van Hook S, Harris SK, Brooks T et al (2007) The “Six T’s”: barriers to screening teens for substance abuse in primary care. J Adolesc Health 40:456–461
Von Ranson KM, Iacono WG, McGue M (2002) Disordered eating and substance use in an epidemiological sample: I. Associations within individuals. Int J Eat Disord 31:389–403
Waldron HB, Turner CW (2008) Evidence-based psychosocial treatments for adolescent substance abuse. J Clin Child Adolesc Psychol 37(1):238–261
Wilens TE, Faraone SV, Biederman J et al (2003) Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111(1):179–185
Wilens TE, Adamson J, Monuteaux MC et al (2008) Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med 162(10):916–921
Wilens TE, Martelon MK, Joshi G et al (2011) Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry 50(6):543–553
Williams RJ, Chang SY (2000) A comprehensive and comparative review of adolescent substance abuse treatment outcome. Clin Psychol Sci Pract 7:138–166
Winters KC, Kaminer Y (2008) Screening and assessing adolescent substance use disorders in clinical populations. J Am Acad Child Adolesc Psychiatry 47(7):740–744
Winters KC, Stinchfield RD, Opland E et al (2000) The effectiveness of the Minnesota model approach in the treatment of adolescent drug abusers. Addiction 95(4):601–612
Winters KC, Stinchfield RD, Latimer WW et al (2008) Internalizing and externalizing behaviors and their association with the treatment of adolescents with substance use disorder. J Subst Abuse Treat 35:269–278
Woody GE, Poole SA, Subramaniam G et al (2008) Extended vs treated short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA 300(17):2003–2011
Wu L-T, Ringwalt CL, Mannelli P et al (2008) Prescription pain reliever abuse and dependence among adolescents: a nationally representative study. J Am Acad Child Adolesc Psychiatry 47(9):1020–1029
Young SE, Corley RP, Stallings MC et al (2002) Substance use, abuse and dependence in adolescence: prevalence, symptom profiles and correlates. Drug Alcohol Depend 68:309–322
Acknowledgment
We gratefully acknowledge Jennifer Goldberg, BA, for all her hard work and help with the literature review for and editing of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Italia
About this entry
Cite this entry
Milin, R., Walker, S. (2015). Adolescent and Substance Abuse. In: el-Guebaly, N., Carrà, G., Galanter, M. (eds) Textbook of Addiction Treatment: International Perspectives. Springer, Milano. https://doi.org/10.1007/978-88-470-5322-9_124
Download citation
DOI: https://doi.org/10.1007/978-88-470-5322-9_124
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5321-2
Online ISBN: 978-88-470-5322-9
eBook Packages: MedicineReference Module Medicine